Unlocking Neurological Innovation Through Proprietary Data and AI

Real World Data

NOVA Neuro is transforming the landscape of real-world data (RWD) by capturing standardized, longitudinal clinical data from diverse patient populations and integrating electronic health records (EHR), imaging, surgical details, and patient-reported outcomes into a unified, high-quality dataset that supports more inclusive research, accelerates evidence generation, and drives meaningful improvements in neurological care.

Clinical Trial Optimization

NOVA is optimizing clinical trials by enabling real-time identification of eligible patients through its integrated data platform, significantly reducing time-to-enrollment and improving trial efficiency. By streamlining recruitment and aligning trials with real-world clinical workflows, we accelerate innovation while enhancing patient access and outcomes.

Real World Evidence

NOVA is generating robust real-world evidence by applying AI and machine learning tools to longitudinal clinical data. This enables us to identify treatment responses, detect safety signals, and assess long-term efficacy across diverse patient populations. Our platform supports surveillance, regulatory reporting, and value-based care by providing high-quality evidence to payers, providers (including ourselves), and a range of innovators

Biomarker Discovery

NOVA Neuro is advancing biomarker discovery by generating comprehensive multi-omics data paired with powerful AI and machine learning capabilities. This integrated approach enables us to identify novel biomarkers with high specificity and sensitivity for early diagnosis, disease progression monitoring, and therapeutic response prediction.